Elaborate
PrivateLast Round
Seed
Jan 26, 2023
Total Funding Raised
$10M
Company Overview
Elaborate is a healthtech company that provides a clinical intelligence platform to automate inbox workflows and contextualize patient communications for healthcare practitioners.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Workflow Automation, Vertical SaaS, EHR & EMR, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elaborate Comparables
Compare Elaborate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Affineon Health | 85% | |
| Droxi | 85% | |
| Switchboard, MD | 81% |
Elaborate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 26, 2023 |
Elaborate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Founder Collective | Seed |
| Company Ventures | Seed |
| Company Ventures | Seed |
| Tusk Venture Partners | Seed |
| Arkitekt Ventures | Seed |
| Bling Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 18, 2026
Added Northwestern Medical Group, an enterprise healthcare organization, as a customer.
- Sep 16, 2025
Added Millennium Physician Group, a healthcare company, as a customer.
Elaborate Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Elaborate's valuation, stock price, and market status.
Is Elaborate a public or private company?
Elaborate is a private company.
What is the current stock price of Elaborate?
Elaborate is a private company with no public stock price. No recent secondary market data is available.
How much is Elaborate worth (valuation)?
Valuation information for Elaborate is not publicly available.
Can I buy Elaborate stock?
Elaborate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Elaborate's last funding round?
Elaborate's most recent funding round was Seed on January 26, 2023.
Who are the main investors in Elaborate?
Key investors in Elaborate include Tusk Venture Partners.
Will Elaborate IPO soon?
No public IPO plans have been announced for Elaborate.
How can I track Elaborate secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Elaborate's secondary market activity and sign up for updates.